[Influenza].
Sugaya
Norio
N
Department of Pediatrics, Keiyu General Hospital.
D000081:Acetamides / Q000627:therapeutic use; D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006146:Guanidines; D006801:Humans; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control / Q000821:virology; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D053139:Oseltamivir; D011714:Pyrans; D011933:Reagent Kits, Diagnostic; D012794:Sialic Acids / Q000627:therapeutic use; D014613:Vaccines, Attenuated; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D006146:Guanidines; D007252:Influenza Vaccines; D011714:Pyrans; D011933:Reagent Kits, Diagnostic; D012794:Sialic Acids; D014613:Vaccines, Attenuated; D053139:Oseltamivir; D000547:Amantadine; D009439:Neuraminidase; D053243:Zanamivir